Dr Andrew Tan Eik Hock’s early exposure to Nuclear Medicine sparked his interest in targeted radionuclide therapies. He noticed the tremendous potential in the application of Theranostics, the simplicity and elegance of using imaging and therapy to allow doctors to predict responses before undertaking treatment. The concept of theranostics also meant that doctors could potentially find specific delivery agents for all cancers, allowing for very precise treatment of cancers and hopefully a reduction of the potential side effects.
Currently, Dr Andrew Tan Eik Hock is a Consultant Nuclear Medicine Physician and department head of the Farrer Park Hospital (Singapore) Nuclear Medicine Department. He is also a consultant at the Raffles Hospital (Singapore) Nuclear Medicine Center, the medical director at the Mlve Medical Diagnostic Suites (Singapore). He is a visiting consultant at the Asian American Radiation Oncology (AARO), a part of the Asian American Medical Group.
After completing his MBBS at the National University of Singapore (NUS) in 2001, he was admitted as a Fellow of the Royal College of Radiologists in the United Kingdom in 2008. Dr Andrew Tan Eik Hock was later recognised as a Fellow at the Academy of Medicine Singapore (College of Radiology) in 2009. Subsequently, he was awarded a Diplomate in Nuclear Cardiology from the Certification Board of Nuclear Cardiology (United States) in 2011.
Dr Andrew Tan Eik Hock has undergone multiple training stints in various internationally recognised medical centres in the development of his career. These include Zentralklinik Bad Berka (Germany), Innsbruck Medical University (Austria), European Institute of Oncology (Milan), and Austin Health (Australia).
He was a member of the Singapore General Hospital (SGH) team that initiated the Peptide Radionuclide Receptor Therapy (PRRT) services locally and introduced the radioisotope occult lesion localisation (ROLL) technique.
Dr Andrew Tan Eik Hock is published in multiple international peer-reviewed journals, with multiple articles in journals such as the British Journal of Radiology, Clinical Nuclear Medicine, Journal of Nuclear Medicine, and the European Journal of Nuclear Medicine and Molecular Imaging. He has contributed book chapters in neuroendocrine tumours, breast and lung cancers, and in his career has initiated and participated in multiple investigator and industry initiated clinical trials.
Being active in the medical community, he served as the President of the Singapore Radiological Society (2016-2020) and the President of the ASEAN Association of Radiology (2019-2021). Dr Andrew Tan Eik Hock was also awarded honorary membership of the American Roentgen Ray Society in 2019 and is a member of the World Association of Radiopharmaceutical and Molecular Therapy.
He has an interest in Medical Informatics and Technology and was previously consulting to various technology groups, including National Computer Systems (Singapore), Accenture (Health and Public Services operating group), and Booz and Company. He is currently appointed as a medical advisor to several medical technology start-ups involved in Artificial Intelligence and Teleimaging services.
In his time away from work, Dr Andrew Tan Eik Hock ensures that he sets time aside for exercise and sport together with his wife and children, understanding the importance of a balanced lifestyle and the benefits of keeping his mind and body alert and active.
